Ticker

Analyst Price Targets — LYEL

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
December 9, 2025 11:14 amH.C. Wainwright$45.00$28.36TheFly Lyell Immunopharma upgraded to Buy from Neutral at H.C. Wainwright
November 24, 2025 11:15 amH.C. Wainwright$20.00$19.13TheFly Lyell Immunopharma price target raised to $20 from $10 at H.C. Wainwright
October 30, 2024 6:05 amGeoff MeachamBank of America Securities$1.00$0.95TheFly Lyell Immunopharma downgraded to Underperform from Buy at BofA
November 14, 2022 6:18 amMorgan Stanley$7.00$4.53Benzinga Morgan Stanley Downgrades Lyell Immunopharma to Equal-Weight, Lowers Price Target to $7
May 24, 2022 10:09 amGoldman Sachs$12.00$4.01Benzinga Goldman Sachs Maintains Buy on Lyell Immunopharma, Lowers Price Target to $12

Latest News for LYEL

Lyell Immunopharma Announces Closing of Additional $50 Million Tranche of Equity Private Placement and Appointment of Smital Shah as Chief Financial and Business Officer

SOUTH SAN FRANCISCO, Calif., March 09, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced it has closed the sale of an additional $50 million of shares of its common stock to investors from its July 2025 equity private placement of up to $100…

GlobeNewsWire • Mar 9, 2026
Lyell Immunopharma Announces Participation in March Investor Conferences

SOUTH SAN FRANCISCO, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical-stage company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell therapies for patients with cancer, today announced that members of its senior management team will present and participate in the following investor conferences: TD Cowen 46th Annual Health Care Conference on…

GlobeNewsWire • Feb 23, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for LYEL.

No House trades found for LYEL.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top